Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JELENA KUNOVAC

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1851402259
CMS profile
38079
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$360,068.01

333 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 7; records 101–150 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JELENA KUNOVAC

NPI 1851402259 · CMS profile ID 38079

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 7; records 101–150 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851402259?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JELENA KUNOVAC, NPI 1851402259, CMS profile ID 38079. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851402259?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JELENA KUNOVAC, NPI 1851402259, CMS profile ID 38079. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851402259?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JELENA KUNOVAC, NPI 1851402259, CMS profile ID 38079, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 7; records 101–150 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1851402259?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

333 matching records · $360,068.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 333 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 333.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $115.9110/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143261014 CMS
Axsome Therapeutics, Inc. $1,250.0010/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289841 CMS
E.R. Squibb & Sons, L.L.C. $58.6210/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599366 CMS
E.R. Squibb & Sons, L.L.C. $239.2210/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599373 CMS
E.R. Squibb & Sons, L.L.C. $64.0010/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599377 CMS
E.R. Squibb & Sons, L.L.C. $63.0010/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599380 CMS
Otsuka America Pharmaceutical, Inc. $2,808.0010/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118925909 CMS
Axsome Therapeutics, Inc. $1,250.0010/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289849 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $396.9810/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143260993 CMS
Axsome Therapeutics, Inc. $1,250.0010/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289851 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $396.9810/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143260989 CMS
Axsome Therapeutics, Inc. $1,250.0010/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289837 CMS
Vanda Pharmaceuticals Inc. $3,000.0010/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909542 CMS
Vanda Pharmaceuticals Inc. $198.9810/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909544 CMS
Vanda Pharmaceuticals Inc. $225.9010/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909546 CMS
Vanda Pharmaceuticals Inc. $15.0510/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909548 CMS
Vanda Pharmaceuticals Inc. $24.8310/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909550 CMS
Vanda Pharmaceuticals Inc. $124.9910/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133909552 CMS
E.R. Squibb & Sons, L.L.C. $120.4110/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599391 CMS
E.R. Squibb & Sons, L.L.C. $2,419.0010/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599331 CMS
E.R. Squibb & Sons, L.L.C. $29.8610/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599474 CMS
E.R. Squibb & Sons, L.L.C. $29.8610/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599478 CMS
E.R. Squibb & Sons, L.L.C. $49.7510/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599482 CMS
E.R. Squibb & Sons, L.L.C. $49.7510/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599485 CMS
E.R. Squibb & Sons, L.L.C. $15.0010/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599489 CMS
E.R. Squibb & Sons, L.L.C. $30.0010/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599493 CMS
E.R. Squibb & Sons, L.L.C. $447.6510/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599497 CMS
E.R. Squibb & Sons, L.L.C. $226.8610/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599501 CMS
E.R. Squibb & Sons, L.L.C. $124.9910/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599505 CMS
E.R. Squibb & Sons, L.L.C. $58.3310/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599521 CMS
Otsuka America Pharmaceutical, Inc. $123.9010/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118925907 CMS
E.R. Squibb & Sons, L.L.C. $474.4610/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599440 CMS
E.R. Squibb & Sons, L.L.C. $187.5010/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599447 CMS
E.R. Squibb & Sons, L.L.C. $564.1110/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599451 CMS
Axsome Therapeutics, Inc. $1,250.0010/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289817 CMS
Otsuka America Pharmaceutical, Inc. $2,808.0009/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118925905 CMS
E.R. Squibb & Sons, L.L.C. $580.9509/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599455 CMS
E.R. Squibb & Sons, L.L.C. $201.5009/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599459 CMS
E.R. Squibb & Sons, L.L.C. $201.6009/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599463 CMS
E.R. Squibb & Sons, L.L.C. $131.5309/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599466 CMS
E.R. Squibb & Sons, L.L.C. $109.6909/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599384 CMS
Otsuka America Pharmaceutical, Inc. $20.9009/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118925903 CMS
E.R. Squibb & Sons, L.L.C. $2,765.0009/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599350 CMS
E.R. Squibb & Sons, L.L.C. $30.2509/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599338 CMS
E.R. Squibb & Sons, L.L.C. $64.9209/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599346 CMS
E.R. Squibb & Sons, L.L.C. $16.2509/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599362 CMS
E.R. Squibb & Sons, L.L.C. $6,913.0009/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599358 CMS
Axsome Therapeutics, Inc. $1,250.0009/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148289789 CMS
E.R. Squibb & Sons, L.L.C. $19.9909/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101599354 CMS
Alkermes, Inc. $960.0008/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124784509 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $223,872.37 238
PY2020 $44,276.72 43
PY2021 $95,839.86 71
PY2022 $79,085.09 58
PY2023 $215,061.30 175
PY2024 $360,068.01 333
PY2025 $222,758.73 205

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $223.77 1
PY2025 Principal investigator $612,819.65 21
PY2024 Principal investigator $13,776.84 3
PY2023 Principal investigator $216,647.70 24
PY2022 Principal investigator $1,208,041.81 197
PY2021 Principal investigator $2,988,202.39 371
PY2020 Principal investigator $2,915,916.91 264
PY2019 Recipient $4,976.89 25
PY2019 Principal investigator $3,194,917.30 259

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 BioXcel Therapeutics, Inc. $3,592.79 12/09/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698346
Principal investigator 1 ABBVIE INC. $13,750.00 12/04/2025 Non-covered Recipient Entity
REDBIRD RESEARCH LLC
A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects with Major Depressive Disorder No dispute reported 06/30/2026 1202526942
Principal investigator 1 Vanda Pharmaceuticals Inc. $18,200.00 11/25/2025 Non-covered Recipient Entity
REDBIRD RESEARCH LLC
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder No dispute reported 06/30/2026 1232947016
Principal investigator 1 BioXcel Therapeutics, Inc. $21,200.00 11/17/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698322
Principal investigator 1 BioXcel Therapeutics, Inc. $5,150.00 11/04/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698296
Principal investigator 1 BioXcel Therapeutics, Inc. $12,432.46 10/06/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698260
Principal investigator 1 Vanda Pharmaceuticals Inc. $18,200.00 10/01/2025 Non-covered Recipient Entity
REDBIRD RESEARCH LLC
Randomized Withdrawal Study in Patients With Schizophrenia No dispute reported 06/30/2026 1232946427
Principal investigator 1 BioXcel Therapeutics, Inc. $21,121.25 09/15/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698224
Principal investigator 1 BioXcel Therapeutics, Inc. $18,899.30 09/15/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698226
Principal investigator 1 BioXcel Therapeutics, Inc. $30,416.41 08/11/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698196
Principal investigator 1 BioXcel Therapeutics, Inc. $24,060.88 08/11/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698198
Principal investigator 1 BioXcel Therapeutics, Inc. $50,520.07 07/08/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698174
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $31,205.46 06/24/2025 Non-covered Recipient Entity
Redbird Research
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235994347
Principal investigator 1 BioXcel Therapeutics, Inc. $90,521.85 06/19/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698104
Principal investigator 1 BioXcel Therapeutics, Inc. $29,607.85 06/19/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698106
Principal investigator 1 BioXcel Therapeutics, Inc. $70,589.98 05/20/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228698038
Principal investigator 1 BioXcel Therapeutics, Inc. $70,917.74 04/10/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228697973
Principal investigator 1 BioXcel Therapeutics, Inc. $31,500.00 04/10/2025 Non-covered Recipient Entity
REDBIRD RESEARCH
BXCL501401 No dispute reported 06/30/2026 1228697975
Principal investigator 1 Janssen Research & Development, LLC $46,666.00 04/04/2025 Non-covered Recipient Entity
REDBIRD RESEARCH LLC
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175246146
Recipient Eli Lilly and Company $223.77 03/05/2025 Covered Recipient Physician A PHASE 2, DOUBLE-BLIND, PROOF OF CONCEPT STUDY TO EVALUATE MAZDUTIDE COMPARED WITH PLACEBO IN PARTICIPANTS WITH ALCOHOL USE DISORDER No dispute reported 06/30/2026 1187871683
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,500.00 01/29/2025 Non-covered Recipient Entity
ALEA RESEARCH INC
AN OPEN-LABEL, MULTICENTER TRIAL TO ASSESS THE SAFETY AND TOLERABILITY OF LUMATEPERONE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER No dispute reported 06/30/2026 1242329873
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $767.61 01/29/2025 Non-covered Recipient Entity
ALEA RESEARCH INC
AN OPEN-LABEL, MULTICENTER TRIAL TO ASSESS THE SAFETY AND TOLERABILITY OF LUMATEPERONE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER No dispute reported 06/30/2026 1242329875